TargetedOnc.com provides the latest news and insight focused on next generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying recent and up-to-date with the future of cancer therapeutics. As such, TargetedOnc strives to provide the latest information on breaking news and updates on the burgeoning field. TargetedOnc focuses on the next stage of cancer development, focusing on cutting edge therapies and their biological targets. Content is organized by tumor type, news, and conference coverage.
Silas Inman, Director of Editorial and Multimedia, graduated with a bachelor's degree from Eastern Michigan University.
Connect with Silas